-
801
Multicomponent rehabilitation to improve independence and functioning in elderly patients with common age-associated diseases: a scoping review
Published 2025-01-01“…This review mapped the evidence on MR in elderly patients following hospitalisation for age-related conditions regarding functioning-related outcomes.Design Scoping review.Data sources PubMed, Cochrane Library, International Clinical Trials Registry Platform and ClinicalTrials.gov (searched through 24 June 2024).Eligibility criteria We included randomised controlled trials (RCT) and controlled cohort studies (CCS) comparing centre-based MR with usual care (medical care excluding exercise training) in patients ≥75 years, hospitalised for age-related cardiac, neurological, oncological and orthopaedic diseases. …”
Get full text
Article -
802
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
Published 2025-01-01“…The trial is registered at the EU Clinical Trials Register (EU-CT number 2023-505377-32) and ClinicalTrials.gov (NCT06220032). …”
Get full text
Article -
803
The Role of Lactobacillus reuteri DSMZ17648 for Helicobacter pylori eradication therapy (Review of literature and advisory council resolution, February 28, 2018)
Published 2018-08-01“…Potential of PylopassTM combination to various H. pylori eradication therapy modes is a subject offutnet multicenter randomized clinical trials for assessment of optimal combination to antibiotic drugs, treatment duration and adverse effect rates. …”
Get full text
Article -
804
Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States
Published 2023-12-01“…Continued efforts to understand how people with HIV experience ATIs will improve future designs of HIV cure clinical trials.…”
Get full text
Article -
805
Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy
Published 2025-01-01“…Conclusions xiRB49-MMAE is a promising drug candidate for clinical trials in ETB + tumors. RB49 could be used as a diagnostic tool for patient stratification.…”
Get full text
Article -
806
Experiences, perceptions and ethical considerations of the malaria infection study in Thailand
Published 2025-01-01“…Trial registration This manuscript is part of the clinical trials registered under ClinicalTrials.gov IDs NCT04083508 (MIST1) registered on 5 Sep 2019 and NCT05071079 (MIST2) registered on 28 July 2021. …”
Get full text
Article -
807
European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD).
Published 2025-01-01“…The eurIPFreg and eurIPFbank are listed in ClinicalTrials.gov (NCT02951416). EurILDreg is registered in German Clinical Trials Register, DRKS 00028968.…”
Get full text
Article -
808
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Published 2025-02-01“…Here, we provide here a comprehensive review of cellular signaling pathways, their therapeutic potential, evidence derived from late-stage clinical trials in HCC and discuss the concepts underlying earlier clinical trials, biomarker identification, and the development of more effective therapeutics for HCC.…”
Get full text
Article -
809
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
Published 2025-01-01“…Trial Registration ClinicalTrials.gov number NCT02513394 Registered 30 Jul 2015.…”
Get full text
Article -
810
-
811
The Canadian Multicentre MAC Treatment Study
Published 1994-01-01“…Collaborative, Canadian, multicentre clinical trials in HIV disease can be successfully implemented.…”
Get full text
Article -
812
To Live or to Die: Prosurvival Activity of PPARγ in Cancers
Published 2008-01-01“…We discuss the following five aspects of the nuclear hormone receptor and its agonists: (1) relative expression of PPARγ in human tumor versus normal tissues; (2) receptor-dependent proneoplastic effects; (3) impact of PPARγ and its agonists on tumors in animal models; (4) clinical trials of thiazolidinediones (TZDs) in human malignancies; (5) TZDs as chemopreventive agents in epidemiology studies. …”
Get full text
Article -
813
Therapeutics in paediatric genetic diseases: current and future landscape
Published 2023-01-01“…Specifically, gene therapy has been shown to be effective in various clinical trials, and indeed, these trials have led to regulatory approvals, paving the way for gene therapies for other types of PGDs. …”
Get full text
Article -
814
Radioimmunotherapy: A Specific Treatment Protocol for Cancer by Cytotoxic Radioisotopes Conjugated to Antibodies
Published 2014-01-01“…This review outlines the fundamentals of RIT and current knowledge of the preclinical/clinical trials for cancer treatment.…”
Get full text
Article -
815
Efficacy of the herbal preparation STW 5 in multi-target therapy of functional dyspepsia
Published 2015-10-01“…Mechanism of action includes effect on motility of the stomach and intestine, visceral sensitivity along with anti-inflammatory and cytoprotective effects. Controlled clinical trials have confirmed high efficacy of Iberogast® at treatment of FD (including pediatric practice) as well as good tolerability of the drug.Conclusion. …”
Get full text
Article -
816
Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control
Published 2012-01-01“…The main objective of cancer phase I clinical trials is to determine a maximum tolerated dose (MTD) of a new experimental treatment. …”
Get full text
Article -
817
Exact Group Sequential Methods for Estimating a Binomial Proportion
Published 2013-01-01“…Illustrative examples are given for applications in clinical trials.…”
Get full text
Article -
818
Sporadic inclusion body myositis in the rheumatology clinic
Published 2020-01-01“…Although there have been no robust clinical trials, training exercise/physiotherapy should be prescribed regularly in sIBM patients.…”
Get full text
Article -
819
Glucocorticoids and Preterm Hypoxic-Ischemic Brain Injury: The Good and the Bad
Published 2012-01-01“…Fetuses at risk of premature delivery are now routinely exposed to maternal treatment with synthetic glucocorticoids. In randomized clinical trials, these substantially reduce acute neonatal systemic morbidity, and mortality, after premature birth and reduce intraventricular hemorrhage. …”
Get full text
Article -
820
The Role of Targeted Therapy in Metastatic Renal Cell Carcinoma
Published 2007-01-01“…This article briefly describes the biological pathways involved in the development of RCC and the results of clinical trials using targeted therapy in metastatic RCC.…”
Get full text
Article